logo-loader
viewFeedback PLC

Full interview: Feedback hails new fluoroscopy technology

Feedback (LON:FDBK) specialises in medical imaging technology, such as magnetic resonance imaging (MRI) scans and X-Rays.
CEO Tom Oakley is a radiologist and understands the niche gaps in the medical imaging market and here he tells Proactive London how he's building a new revenue stream on the back of software already developed.
Oakley explains how his company is rolling out the new fluoroscopy technique, which is basically a x-ray movie, across 200 sites in the US 
and how it doesn't mean expensive new kit for users.
Updates here too on Feedback's flagship Bleepa product, the encrypted medical messaging app used on smartphones, tablets and desktops, allowing clinicians to communicate with other team members securely.

Quick facts: Feedback PLC

Price: 1.025 GBX

LSE:FDBK
Market: LSE
Market Cap: £10.94 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Feedback PLC named herein, including the promotion by the Company of Feedback PLC in any Content on the Site, the Company receives from said...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Feedback's Tom Oakley discusses plans for Bleepa rollout following £5.5mln raise

Feedback's (LON:FDBK) Tom Oakley speaks to Proactive London's Andrew Scott following the news they've raised £5.05mln through a placing plus they're looking to bring in an additional £540k through an open offer to existing shareholders. He says the cash will be used to develop their flagship...

4 weeks ago

2 min read